z-logo
open-access-imgOpen Access
Upregulation of Lnc RNA ‐ HIT promotes migration and invasion of non‐small cell lung cancer cells by association with ZEB 1
Author(s) -
Jia Xiaojing,
Wang Zhicheng,
Qiu Ling,
Yang Yanming,
Wang Yunlong,
Chen Zhishen,
Liu Zhongshan,
Yu Lei
Publication year - 2016
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.948
Subject(s) - rna , lung cancer , downregulation and upregulation , cancer research , metastasis , biology , cancer , oncogene , cell growth , cell cycle , medicine , oncology , gene , genetics
Lung cancer is the most common solid tumor and the leading cause of cancer‐related mortality worldwide. Non‐small cell lung cancer ( NSCLC ) accounts for approximately 80% of all lung cancer cases. The main reason of lung cancer‐related deaths is due to tumor metastasis. But, the mechanisms of NSCLC metastasis remains poorly understood. Lnc RNA s play pivotal roles in multiple biological processes. Lnc RNA ‐ HIT ( HOXA transcript induced by TGF β ) was recently identified. Lnc RNA ‐ HIT promotes cell migration, invasion, tumor growth, and metastasis. However, the detailed role of lnc RNA ‐ HIT in NSCLC remains unknown. In this study, for the first time, we revealed a novel role of lnc RNA ‐ HIT in the migration and invasion of NSCLC cells. The expression of lnc RNA ‐ HIT was significantly upregulated in NSCLC tissues and cell lines, and the expression level of lnc RNA ‐ HIT correlates with advanced disease stage and predicts unfavorable prognosis of NSCLC patients. Functional assays demonstrated that lnc RNA ‐ HIT markedly increased the ability of NSCLC cells to migrate and invade. Furthermore, the molecular mechanism by which lnc RNA ‐ HIT affects NSCLC cells was associated with regulation of ZEB 1 stability. Lnc RNA ‐ HIT functions as a prometastasis oncogene by directly associating with ZEB 1 to regulate NSCLC . The interaction of lnc RNA ‐ HIT and ZEB 1 may be a potential target for NSCLC therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom